← Leaderboards
Lynn Rose
Sequella, Inc.
$26,000
Attributed
$26,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$26,000 · 1
By mechanism
RC1$26,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Sequella, Inc.
Same institution · by research overlap
- Marina N Protopopova$5,540,511
- Leo Einck$3,287,911
- Matthew Charles Mulvey$684,296
- Lisa Beth Ferstenberg$385,653
- Boris V Nikonenko$299,045
Others in their field
Top investigators on “Antitubercular Agents”
- David Alland · Rutgers Biomedical And Health Sciences$14,918,108
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$13,387,732
- Mina C Hosseinipour · Univ Of North Carolina Chapel Hill$13,387,732
- John R. Chan · Rutgers Biomedical And Health Sciences$11,578,548
- Mark Fredric Cotton · Stellenbosch University$11,071,445
- Chinnaswamy Jagannath · University Of Texas Hlth Sci Ctr Houston$10,931,439
Research focus
Antitubercular AgentsClinical ResearchClinical Trial Phase IDosageDrug Design /Synthesis /ProductionHuman SubjectHuman Therapy EvaluationMicroorganism Disease ChemotherapyMycobacterium TuberculosisPharmacokineticsTuberculosis